What is arthritis?

January 19, 2022

Arthritis

Arthritis is the swelling and tenderness of one or more of your joints. The main symptoms of arthritis are joint pain and stiffness, which typically worsen with age. In addition, patients can present inflammation, redness and lack of movement. The most common types of arthritis are osteoarthritis (OA) and rheumatoid arthritis (RA).

 

A reduction in the normal amount of this cartilage tissue causes some forms of arthritis. Normal wear and tear causes OA, the most common type of arthritis. An infection or injury to the joints can exacerbate this natural breakdown of cartilage tissue. Your risk of developing OA may be higher if you have a family history of the disease.


RA, is an autoimmune disorder. It occurs when your body’s immune system attacks the tissues of the body. These attacks affect the cartilage and the joints. RA can eventually lead to the destruction of both bone and cartilage inside the joint.


The most common signs and symptoms of arthritis affect the joints. Symptoms can appear and disappear; can be mild, moderate or severe. Severe arthritis can result in chronic pain, incapacity to realize daily living activities and difficulty walking or using stairs. It is important to know that even if some changes are visible commonly the damage can only be seen through a radiography. Less common types of arthritis can also affect the heart, eyes, skin, and kidneys. 


Another type of arthritis is
psoriatic arthritis, a form of arthritis that affects some people that have psoriasis. Sometimes the problems in the arteries appear before the skin findings that characterize psoriasis. These arthritic problems can arise in any artery of the body including fingers, column and intensity can vary from low to severe. People that suffer from psoriatic arthritis can have periods of high disease activity and some periods of remission. Currently there isn’t a cure for psoriatic arthritis this is why current treatment focuses on controlling symptoms and preventing damage to the articulations.   






What are the risk factors for developing arthritis? 


  • Family history:
    Some types of arthritis run in families, so you may be more likely to develop arthritis if your parents or siblings have the disorder. Your genes can make you more susceptible to environmental factors that may trigger arthritis.
  • Age: The risk of many types of arthritis including osteoarthritis, rheumatoid arthritis and gout increases with age.
  • Sex: Women are more likely than men to develop rheumatoid arthritis, while most of the people who have gout, another type of arthritis, are men.
  • Previous joint injury: People who have injured a joint, perhaps while playing a sport, are more likely to eventually develop arthritis in that joint.
  • Obesity: Carrying excess pounds puts stress on joints, particularly your knees, hips and spine. People with obesity have a higher risk of developing arthritis.


What are the possible treatments for arthritis?

In terms of treatment, the main goal is to reduce the amount of pain you are experiencing and prevent further joint damage. Some people find heating pads and ice packs relaxing. Others use assistive mobility devices, such as canes or walkers, to help relieve pressure on sore joints. Arthritis treatments can help reduce inflammation in your joints, relieve pain, prevent or delay joint damage, reduce disability, and allow you to be as active as possible.

It is also important to improve the function of your joints. Your doctor can prescribe a combination of treatment methods to achieve the best results.


Medical treatments: 

  • Pain relievers, such as hydrocodone or acetaminophen, are effective in controlling pain, but they do not help decrease inflammation.
  • Nonsteroidal anti-inflammatory drugs, such as ibuprofen and salicylates, help control pain and inflammation. Salicylates can thin the blood, so they should be used with great caution with additional blood-thinning medications. Avoid it if you are allergic to aspirin.
  • Menthol or capsaicin creams block the transmission of pain signals from the joints. 
  • Immunosuppressants such as prednisone and cortisone can help reduce the inflammation. 





How can my lifestyle help me control arthritis? 

  • Losing weight or maintaining a healthy weight: This reduces the risk of developing OA and can reduce symptoms if you already have it. A diet high in antioxidants, such as fresh fruits, vegetables, and herbs is recommended and can help reduce inflammation. Other foods that reduce inflammation are fish and nuts. For people who are overweight or obese, losing weight reduces pressure on the joints, particularly weight-bearing joints like the hips and knees. Losing 10 to 12 pounds can reduce pain and improve function for people with arthritis. Avoid eating fried foods, processed foods, dairy products, and a high intake of meat

  • Exercise
    : Staying active will keep your joints flexible. Swimming, walking, or biking are often a good form of exercise for people with arthritis because they don't put pressure on the joints. These forms of exercise are usually recommended by doctors for arthritis patients. It is recommended that you exercise for 30-40 minutes most days of the week. Staying active is important, but you also need to make sure you rest when you need to and avoid overexerting yourself.




References: 


A stethoscope is laying on a piece of paper next to a pen
December 12, 2024
URAC accreditation reflects ProCare Rx’s commitment to achieving and maintaining the highest quality, member engagement and experience, and operational standards for PBMs in the industry
By Mc-Rx Team November 15, 2024
Mental health parity and medication adherence
By MC-Rx Clinical Team August 7, 2024
Understanding GLP-1 Medications The landscape of obesity management is evolving, with GLP-1 receptor agonist (RA) medications emerging as a significant player. These FDA-approved drugs have proven effective in helping individuals lose weight, prompting a shift in how they are viewed and covered by health plans. However, the cost implications and strategic decisions surrounding these medications require careful consideration by employer groups and their members. The Case for GLP-1 Medications GLP-1 RAs, originally developed for diabetes management, have shown remarkable efficacy in weight loss. With the growing prevalence of obesity and its associated healthcare costs, there's increasing pressure on health plans to cover these medications. Despite their high cost—annual retail pharmacy expenses can exceed $10,000 per patient—GLP-1 RAs offer potential downstream savings by reducing obesity-related comorbidities such as diabetes, hypertension, and cardiovascular disease​​. Balancing Coverage and Cost Historically, weight loss medications were deemed "lifestyle" drugs and excluded from coverage. However, the rising popularity of GLP-1 RAs and their demonstrated benefits are challenging this perspective. For plan sponsors, the decision to cover these medications involves balancing the high upfront costs with the potential for long-term savings on medical expenses related to obesity. Cost-Containment Strategies For payers choosing to cover GLP-1 medications, several cost-containment strategies can be employed: Formulary Management : Deciding on the placement of these medications within the formulary is crucial. Options range from not covering the drugs to placing them on a high-cost tier with patient cost-sharing. Prior Authorization and Step Therapy : Implementing these measures ensures that only patients with a proper diagnosis (e.g., ICD-10 code for obesity) access these medications, preventing misuse and overutilization. Prerequisite Programs : Requiring participation in wellness or nutrition programs before approving weight loss medications can encourage lifestyle modifications that complement pharmacological treatment. Specialist Restrictions : Limiting prescriptions to weight loss specialists, such as bariatric doctors or endocrinologists, ensures appropriate therapy and monitoring. Duration Limits : Establishing treatment guidelines, such as discontinuing medications if a target weight loss is not achieved within six months, helps manage long-term costs​​. The Role of Brokers and Employer Groups Brokers play a pivotal role in guiding employer groups through the complexities of covering GLP-1 medications. Understanding the cost-benefit dynamics and available cost-containment strategies enables brokers to provide informed recommendations that align with their clients' financial and health objectives. Employer groups, in turn, must weigh the potential benefits of covering these medications against their budgetary constraints and the overall well-being of their workforce. Member Education and Engagement Effective communication with members is essential to ensure they understand the coverage options and adhere to prescribed treatments. Educational initiatives can include: Patient Communication Programs : Providing information on medication adherence, compliance, and lifestyle modifications. Continuing Education : Ongoing programs to keep members informed about the benefits and proper use of weight loss medications. Monitoring and Support : Utilizing pharmacy and medical data to track outcomes and adjust strategies as needed​​. Balance the Scale with Expert Guidance from MC-Rx The adoption of GLP-1 medications for weight loss represents a significant advancement in obesity management. However, the high costs associated with these drugs necessitate careful planning and strategic implementation by brokers, employer groups, and members. By employing robust cost-containment strategies and prioritizing member education, health plans can navigate the financial challenges while delivering meaningful health benefits to their populations. MC-Rx, as a full-service pharmacy benefits manager, offers the expertise and tools to help clients optimize their coverage decisions and manage the complexities of incorporating GLP-1 medications into their health plans. Here are just a few of the GLP-1 strategies we use to shield our clients from excessive costs: Implementation of Drug Management Tools, which is critical to ensure proper utilization for GLP-1s. Strategic Benefit Design, which also protects clients from improper GLP-1 utilization. Clear Member Communication, which is crucial for proper adherence and compliance. When implemented with an existing client, the above-listed strategies helped them achieve $382,000 in cost avoidance for GLP-1s. With the right approach, the benefits of these medications can be realized, contributing to better health outcomes and potentially lowering overall healthcare costs in the long run. For more information on managing GLP-1 medications and other pharmacy benefits, reach out to an MC-Rx expert today .
By MC-Rx Clinical Team August 2, 2024
Mental Health Parity and Medication Adherence
March 21, 2024
MC-Rx, powered by ProCare Rx, has been notified by the Academy of Managed Care Pharmacy (AMCP) of the acceptance of their abstract, “Improving Adherence to HIV PREP via a PBM-Driven Educational Intervention” , for presentation at AMCP 2024 Conference in April.
February 23, 2024
Exploring the rising costs and demands of weight-loss medication and how to combat those costs, significantly lowering drug costs for payors and increasing access for patients who need them.
January 16, 2024
A message from Marileny Lugo, President, MC-Rx
January 16, 2024
A message from Marileny Lugo, President, MC-Rx
January 10, 2024
To decrease the burden on healthcare costs, at MC-Rx we strive to create awareness by educating our community regarding the importance of prevention.
September 28, 2023
Increased medication adherence has been linked to better clinical and financial outcomes.
More Posts
Share by: